All News


ePT--the Electronic Newsletter of Pharmaceutical Technology

The US Department of Health and Human Services's Biomedical Advanced Research and Development Authority has awarded Novartis a contract valued up to $486 million over eight years to support the design, construction, validation, and licensing of a US cell-based influenza vaccine manufacturing facility in Holly Springs, North Carolina.

ePT--the Electronic Newsletter of Pharmaceutical Technology

The US Food and Drug Administration announced that it had filed a Consent Decree on Dec. 23, 2008 and was awaiting the court?s entry of a permanent injunction that bars Actavis (Hafnarfjordur, Iceland), its officers Sigurdur Oli Olafsson and Douglas Boothe, and its subsidiary Actavis Totowa (Totowa, NJ) from manufacturing and distributing drugs at the Actavis Totowa facilities.

ePT--the Electronic Newsletter of Pharmaceutical Technology

Frank Torti, currently principal deputy commissioner and chief scientist of the US Food and Drug Administration, will take over as FDA's acting commissioner next week, according to an official with the US Department of Health and Human Services (HHS).

ePT--the Electronic Newsletter of Pharmaceutical Technology

A December report on healthcare from the Congressional Budget Office (CBO) proposes that an abbreviated regulatory process for follow-on biologics could result in more than $10 billion in savings by the year 2020.

ePT--the Electronic Newsletter of Pharmaceutical Technology

The generic-drug manufacturer Actavis reached an agreement on a consent decree of permanent injunction with the US Food and Drug Administration regarding the company?s US subsidiary Actavis Totowa LLC.

ePT--the Electronic Newsletter of Pharmaceutical Technology

A California jury ordered Pfizer (New York) to pay $38 million to the Ischemia Research and Education Foundation (IREF), a medical-research nonprofit group, for stealing trade secrets to develop its "Bextra" analgesic.

PTSM: Pharmaceutical Technology Sourcing and Management

Achieving double-digit growth through 2011, biotech-based active pharmaceutical ingredients (APIs) are expected to far surpass growth rates for chemically synthesized APIs.

i4-575304-1408667695178.jpg

Although its domestic market is on the rise, Pakistan's market conditions have not proved welcoming enough to keep foreign investors.

i1-575303-1408667698822.jpg

An Ounce of Rejection

Readers give advice on their best approach to handling (batch) rejection

i1-574852-1408668111334.jpg

Pharmaceutical Technology Europe

Christmas is over. Everybody is back at work feeling a bit hungover, a lot poorer and alarmingly heavier...

ePT--the Electronic Newsletter of Pharmaceutical Technology

A newly released study from the US Food and Drug Administration demonstrates that the printed information retail pharmacies provide to patients regarding medication use and risk of their prescriptions is not easy to read or understand.